论文部分内容阅读
上消化道出血常发生在使用类固醇及非类固醇抗炎药物治疗时.本研究的目的是评价生长激素释放抑制因子(somatostatin)对治疗医源性上消化道出血的疗效,并和呋喃硝胺及安慰剂作比较.作者对60例年龄均小于60岁的急性上消化道出血患者进行研究.他们均因各种并存的疾病而接受非类固醇抗炎药物或皮质类固醇治疗。包括出血性胃病31例,胃溃疡15例,十二指肠溃疡14例。所有患者都作紧急内窥镜检查并插胃管,均未应用抗酸
Upper gastrointestinal bleeding occurs when steroids and non-steroidal anti-inflammatory drugs are used.The purpose of this study was to evaluate the efficacy of somatostatin in the treatment of iatrogenic upper gastrointestinal bleeding and to evaluate the efficacy of somatostatin against furanitamide and Placebo for the study of 60 patients aged less than 60 years of acute upper gastrointestinal bleeding were studied because of a variety of coexisting diseases they receive non-steroidal anti-inflammatory drugs or corticosteroids. Including hemorrhagic stomach in 31 cases, 15 cases of gastric ulcer, 14 cases of duodenal ulcer. All patients underwent emergency endoscopy and gastric tube insertion. None of the patients received acid-fast